T 2152/22 (RNA-containing particles/HIGHLIGHT) of 04.04.2023

European Case Law Identifier: ECLI:EP:BA:2023:T215222.20230404
Date of decision: 4 April 2023
Case number: T 2152/22
Online on: 12 April 2023
Petition for review of: -
Application number: 16805990.5
IPC class: A61K 9/19 A61K 31/713 A61K 47/26 A61P 35/00 A61K 9/08 A61K 47/69
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES COMPRISING A COMPLEX OF A DOUBLE-STRANDED POLYRIBONUCLEOTIDE AND A POLYALKYLENEIMINE
Applicant name: Highlight Therapeutics, S.L.
Opponent name: TargImmune Therapeutics AG
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 108 European Patent Convention R 99(2)European Patent Convention R 101(1)
Keywords: Admissibility of appeal - missing statement of grounds
Catchword: -
Cited cases: -
Citing cases: -

Order

For these reasons it is decided that:

The appeal is rejected as inadmissible.